Compounded semaglutide in Dallas: how the program works at Privé Aesthetics

Compounded semaglutide at Privé Aesthetics is a GLP-1 receptor agonist prescribed as part of a medically supervised weight-loss program in Highland Park, Dallas — compounded at a U.S. licensed, FDA-registered pharmacy, prescribed under physician supervision by Medical Director Dr. Gregory Gardner, DO, with lab work and monthly check-ins included. It is not a quick fix; it is a structured monthly program.

Compounded semaglutide is, for many patients, the entry point into the GLP-1 conversation — the more established single-mechanism molecule, at a lower monthly price than its dual-mechanism counterpart. It is also one of the most poorly served topics in aesthetics marketing, which tends to either over-promise a specific weight-loss outcome or under-explain what the monthly program actually involves. This piece is the explanation we wish was easier to find: what compounded semaglutide is, how the molecule works, how Privé structures the program month-by-month, how it compares to compounded tirzepatide, and what we are candid about up front.

What "compounded" actually means

Semaglutide is a peptide molecule that activates a receptor system involved in appetite, gastric emptying, and glucose regulation. The molecule exists in two forms relevant to patient care: as finished pharmaceutical drug products manufactured by branded pharmaceutical companies, and as a compounded preparation formulated at a U.S. licensed, FDA-registered compounding pharmacy under physician prescription.

The compounded version is what Privé prescribes. It is not the same product as the branded finished drug. It is not FDA-approved as a finished drug product; it is a pharmacy-compounded formulation made for the individual patient under prescription, in accordance with applicable state and federal compounding regulations. The pharmacy we work with is licensed in the United States, FDA-registered, and operates under the standards required for sterile compounding.

We do not compare compounded semaglutide to branded finished drug products by name, and we do not claim equivalence in marketing. What we do is provide medically supervised access to a compounded preparation under physician prescription — the same regulatory pathway used by many compounding pharmacies and physician practices in the United States.

How compounded semaglutide works

Compounded semaglutide is a GLP-1 receptor agonist — it activates the GLP-1 receptor (glucagon-like peptide-1), one of the body's natural appetite and glucose-regulating signaling pathways. Unlike compounded tirzepatide, it acts on this single receptor system rather than two.

Mechanistically, compounded semaglutide slows gastric emptying (food stays in the stomach longer, which extends the feeling of satiety), reduces post-meal glucose spikes, and signals appetite-regulation centers in the brain to reduce hunger signaling between meals. The practical experience most patients describe is a quieter relationship with food — smaller portions feel satisfying, and the constant background pull toward snacking softens. How strongly any given patient responds is individual, which is exactly why the program is built around monitoring rather than a fixed protocol.

How the program is structured

The Privé compounded weight-loss program is organized as a monthly subscription with three structural phases.

Phase 1 — consultation, lab work, and titration start (Month 1). The first appointment is a comprehensive consultation with the clinical team. Medical history, current medications, goals, and contraindication screening. Baseline lab work is drawn — complete metabolic panel, lipid panel, A1C, thyroid function, and any additional tests indicated by individual history. Lab work is included in the first-month program fee. Based on the consultation and labs, Dr. Gardner writes the initial prescription; the pharmacy compounds and ships; titration begins at the lowest dose.

Phase 2 — titration through tolerance (Months 2-4 typical). Dose adjustments happen at the pace your body tolerates. Most patients step up through the dose tiers during this phase. Monthly check-ins assess response, side effects, and biometric trends. If side effects are intolerable at a given dose, we hold or step down rather than push through.

Phase 3 — maintenance + monitoring (Months 5 onward). Once the right dose is established, the program continues with monthly prescriptions and check-ins for ongoing monitoring. Lab work is repeated periodically depending on clinical indication. Duration varies by patient goal — some are 6 to 12 month protocols; others continue longer for maintenance.

Compounded semaglutide vs compounded tirzepatide

Privé carries both. Compounded semaglutide activates the GLP-1 receptor only. Compounded tirzepatide activates the GLP-1 receptor and the GIP receptor — a dual mechanism that can produce a different appetite and metabolic response for some patients. Practical differences include cost (compounded semaglutide programs start at $350/month; compounded tirzepatide programs start at $500/month), individual response variability, and side-effect profile. Some patients respond better to one than the other, and some begin on compounded semaglutide and later discuss whether the dual-mechanism molecule is worth exploring. The decision is made at consultation, not by the internet — our full compounded semaglutide vs compounded tirzepatide comparison walks through how we weigh it. Both are available through the same structured compounded weight-loss program.

What to expect — realistic framing

Results vary by individual. Some patients notice appetite changes early; others take longer to find their response. Lifestyle factors — diet quality, exercise, sleep, stress, and especially protein intake during weight loss — substantially influence outcomes. We are upfront about this at consultation. We do not promise specific weight-loss numbers in our marketing because the responsible clinical answer is that the right expectation depends on the patient, their starting point, and how their body responds to titration.

Safety, side effects, and contraindications

The most common side effect is nausea, particularly during dose titration. It is usually transient and eases as the body adjusts. Reduced appetite is the intended mechanism but can occasionally tip into unwanted appetite suppression — we monitor for this. Gastrointestinal effects (constipation or loose stools) are also common during titration and typically settle. Rare but serious risks include pancreatitis and gallbladder events; contraindications include a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, history of pancreatitis, pregnancy, and breastfeeding. The monthly check-in cadence exists partly to catch problems early and adjust before they compound.

Cost transparency

Compounded weight-loss pricing at Privé is published openly: compounded semaglutide starts at $350/month; compounded tirzepatide starts at $500/month. The first month includes consultation and baseline labs. Final pricing depends on dose titration and program duration; we confirm at consultation. Financing options (Cherry, CareCredit) are accepted.

Most clinics do not publish weight-loss program pricing. We do, because patients comparison-shopping deserve to do that math without having to call. The pricing structure also reflects that this is a sustained monthly program, not a single-purchase product.

Who the program is right for

Medically appropriate adults seeking sustainable weight management who can commit to the monthly cadence and tolerate self-administered subcutaneous injection. Patients who want a structured, monitored program rather than ad-hoc treatment. Patients who prefer to begin with a single-mechanism GLP-1 receptor agonist. Patients pairing weight-loss work with broader wellness goals.

Not the right fit: patients seeking dramatic short-term results, patients with any of the contraindications listed above, patients who would skip monthly check-ins, patients looking for a branded finished drug product rather than a compounded preparation, and patients who are pregnant or breastfeeding.

How this fits with other Privé services

Many patients on the weight-loss program layer in additional Privé services for the broader wellness picture: peptide and anti-aging therapy for energy, recovery, and longevity protocols; and IM and IV vitamin therapy for the nutritional support that matters during weight loss. The program is built to integrate, not to be siloed — and the same restraint-first, monitor-and-adjust philosophy runs through all of it.